Recent GILD News
- Gilead’s Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023 • Business Wire • 11/30/2023 01:30:00 PM
- FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White Blood Cells • Dow Jones News • 11/28/2023 08:08:00 PM
- Cabaletta Bio Down as FDA Looks Into Issues With Several Companies' Approved CAR T Drugs • Dow Jones News • 11/28/2023 07:59:00 PM
- Crypto this Friday: Cryptocurrencies Reach New Highs, Kwon’s Extradition Approved, and More • IH Market News • 11/24/2023 06:16:52 PM
- Arcellx Shares Rise Premarket on Expanded Gilead Collaboration • Dow Jones News • 11/15/2023 01:30:00 PM
- Gilead Invests Further in Arcellx, Extends Collaboration • Dow Jones News • 11/15/2023 11:58:00 AM
- Kite and Arcellx Announce Expansion in Strategic Partnership • Business Wire • 11/15/2023 11:00:00 AM
- ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP • PR Newswire (US) • 11/15/2023 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2023 11:21:32 PM
- Gilead Sciences On Track for Largest Percent Decrease Since September 2022 -- Data Talk • Dow Jones News • 11/09/2023 06:26:00 PM
- Gilead Sciences to Present at Upcoming Investor Conferences • Business Wire • 11/09/2023 12:13:00 AM
- Gilead Sciences on Pace for Largest Percent Decrease Since August 2020 -- Data Talk • Dow Jones News • 11/08/2023 04:08:00 PM
- Wednesday’s Wall Street Highlights: Spirit AeroSystems, Upstart, Toast, Upwork, Take-Two, Sleep Number, and more • IH Market News • 11/08/2023 11:59:53 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 10:18:43 PM
- Gilead Sciences 3Q Results Beat Estimates • Dow Jones News • 11/07/2023 09:51:00 PM
- Gilead Sciences Raises 2023 Outlook • Dow Jones News • 11/07/2023 09:49:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:03:24 PM
- Gilead Sciences Announces Third Quarter 2023 Financial Results • Business Wire • 11/07/2023 09:02:00 PM
- Tuesday’s Wall Street Highlights: WeWork, UBS, Sanofi, Alteryx, Intel, and more. • IH Market News • 11/07/2023 12:10:06 PM
- Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-line Treatment for Upper GI Cancers • Business Wire • 11/06/2023 10:00:00 PM
- Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-Line Treatment for Upper GI Cancers • Business Wire • 11/06/2023 10:00:00 PM
- What Will Impact the S&P 500 Index This Week? • Finscreener.org • 11/06/2023 10:35:00 AM
- Gilead to Present Late Breaking Data and Real World Evidence Highlighting Key Hepatitis Indications at The Liver Meeting® 2023 • Business Wire • 11/03/2023 03:00:00 PM
- Gilead and Kite Oncology Present Data Demonstrating Car T-cell Therapy Survival Benefit and Showcasing Latest Advances in Blood Cancer Portfolio at ASH 2023 • Business Wire • 11/02/2023 01:15:00 PM
- Kite and Epic Bio Announce Collaboration to Develop New Therapies for Cancer • Business Wire • 10/31/2023 11:30:00 AM
Coinllectibles Proudly Co-Presented Galek Yangzom's Debut Solo Exhibition, "Patterned Prayer" on the world's first glasses-free 3D tablets • COSG • Dec 4, 2023 8:18 AM
POET Technologies Announces Pricing of US$1.4 Million Underwritten Public Offering of Common Shares and Warrants • POET • Dec 1, 2023 10:17 AM
CGrowth Capital Inc. Sets Stage for Exciting 2024 with Savage Barbell Apparel Expansion • CGRA • Nov 28, 2023 11:15 AM
Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing • IMMX • Nov 28, 2023 10:48 AM
Swifty Global Secures GLI Certification for New Cutting-Edge B2B Gaming Platform • DRCR • Nov 28, 2023 9:15 AM
Nate's Food Co. Successfully Obtains GACC Registration in China, Paving the Way for Contract Execution on Commodities • NHMD • Nov 28, 2023 8:00 AM